Atrial Fibrillation Drugs Market Size By Products (Antiarrhythmic Drugs, Anticoagulant Drugs {Vitamin K Antagonists, Novel Oral Anticoagulants [Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors]}), By Atrial Fibrillation Type (Paroxysmal, Persistent, Permanent), By Application (Heart Rhythm Control, Heart Rate Control) By Route of Administration (Oral, Injectable) By End-use (Hospitals, Cardiac Centres, Ambulatory Surgical Centres) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Apr 2019  |  Report ID: GMI3253  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 350   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Atrial fibrillation drugs industry 3600 synopsis, 2014 - 2025 (USD Million)

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Atrial fibrillation type trends

2.1.4. Application trends

2.1.5. Route of Administration trends

2.1.6. End-use trends

2.1.7. Regional trends

Chapter 3. Atrial Fibrillation Drugs Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025 (USD Million)

3.3. Industry impact factors

3.3.1. Growth drivers

3.3.1.1. Increase in prevalence of cardiovascular diseases in developed regions of North America and Europe

3.3.1.2. Rise in demand and need for unmet atrial fibrillation drug therapy

3.3.1.3. Growing geriatric population in Asia Pacific and Latin America

3.3.1.4. Launch of Direct Oral Anticoagulants (DOACs)

3.3.2. Industry pitfalls & challenges

3.3.2.1. High cost of the anticoagulant drugs

3.3.2.2. Adverse drug side effects

3.3.2.3. Lack of awareness regarding medical therapy in underdeveloped and developing regions

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By atrial fibrillation type

3.4.3. By application

3.4.4. By route of administration

3.4.5. By end-use

3.5. Global atrial fibrillation prevalence, 2017

3.6. Drug approval scenario

3.6.1. U.S. FDA (U.S. Food and Drug Administration)

3.6.2. Europe EMA (European Medicines Agency)

3.6.3. China CFDA (China Drug Administration)

3.6.4. Australia TGA (Australian Therapeutic Goods Administration)

3.7. Proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

3.7.1. North America

3.7.2. Europe

3.7.3. Asia Pacific

3.7.4. Latin America

3.7.5. Middle East and Africa

3.8. Proportion of atrial fibrillation patients on direct oral anticoagulants (DOACs) drug therapy

3.8.1. North America

3.8.2. Europe

3.8.3. Asia Pacific

3.8.4. Latin America

3.8.5. Middle East and Africa

3.9. Atrial fibrillation drugs pricing analysis

3.9.1. Antiarrhythmic drugs

3.9.2. Anticoagulant drugs

3.10. Major atrial fibrillation anticoagulant drugs market share analysis, 2017

3.11. Global atrial fibrillation drugs prescription pattern, 2014 – 2025

3.11.1. Antiarrhythmic drugs

3.11.2. Anticoagulant drugs

3.11.2.1. Vitamin K antagonists (Warfarin)

3.11.2.2. Novel oral anticoagulants (NOACs)

3.11.2.2.1. Direct thrombin inhibitors (Dabigatran - Pradaxa)

3.11.2.2.2. Direct factor Xa inhibitors

3.11.2.2.2.1. Apixaban (Eliquis)

3.11.2.2.2.2. Betrixaban (Bevyxxa)

3.11.2.2.2.3. Edoxaban (Savaysa/Lixiana)

3.11.2.2.2.4. Rivaroxaban (Xarelto)

3.12. Technology landscape

3.12.1. New atrial fibrillation drugs

3.12.1.1. Antiarrhythmic drugs

3.12.1.2. Anticoagulant drugs

3.12.2. Future of drug therapy in atrial fibrillation

3.12.2.1. Antiarrhythmic drugs

3.12.2.2. Anticoagulant drugs

3.13. Porter’s analysis

3.14. Competitive landscape, 2017

3.14.1. Strategy dashboard

3.15. PESTEL analysis

Chapter 4. Atrial Fibrillation Drugs Market, By Product

4.1. Global atrial fibrillation drugs market share, by product, 2018 & 2025

4.2. Antiarrhythmic Drugs

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Anticoagulant Drugs

4.3.1. Market size, by region, 2014 – 2025 (USD Million)

4.3.2. Vitamin K antagonists (VKA)

4.3.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3.3. Novel oral anticoagulants (NOACs)

4.3.3.1. Market size, by region, 2014 – 2025 (USD Million)

4.3.3.2. Direct thrombin inhibitors

4.3.3.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3.3.3. Direct factor Xa inhibitors

4.3.3.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 5. Atrial Fibrillation Drugs Market, By Atrial Fibrillation Type

5.1. Global atrial fibrillation drugs market share, by atrial fibrillation type, 2018 & 2025

5.2. Paroxysmal

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Persistent

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.4. Permanent

5.4.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 6. Atrial Fibrillation Drugs Market, By Application

6.1. Global atrial fibrillation drugs market share, by application, 2018 & 2025

6.2. Heart Rhythm Control

6.2.1. Market size, by region, 2014 – 2025 (USD Million)

6.3. Heart Rate Control

6.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 7. Atrial Fibrillation Drugs Market, By Route of Administration

7.1. Global atrial fibrillation drugs market share, by route of administration, 2018 & 2025

7.2. Oral

7.2.1. Market size, by region, 2014 – 2025 (USD Million)

7.3. Injectable

7.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 8. Atrial fibrillation Drugs Market, By End-use

8.1. Global atrial fibrillation drugs market share by end-use, 2018 & 2025

8.2. Hospitals

8.2.1. Market size, by region, 2014 – 2025 (USD Million)

8.3. Cardiac Centers

8.3.1. Market size, by region, 2014 – 2025 (USD Million)

8.4. Ambulatory Surgical Centers

8.4.1. Market size, by region, 2014 – 2025 (USD Million)

8.5. Others

8.5.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 9. Atrial Fibrillation Drugs Market, By Region

9.1. Global atrial fibrillation drugs market share by region, 2018 & 2025

9.2. North America

9.2.1. Market size, by country, 2014 – 2025 (USD Million)

9.2.2. Market size, by product, 2014 – 2025 (USD Million)

9.2.2.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.2.2.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.2.3. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.2.4. Market size, by application, 2014 – 2025 (USD Million)

9.2.5. Market size, by route of administration, 2014 – 2025 (USD Million)

9.2.6. Market size, by end-use, 2014 – 2025 (USD Million)

9.2.7. U.S.

9.2.7.1. Market size, by product, 2014 – 2025 (USD Million)

9.2.7.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.2.7.1.1.1. Market size, by Novel oral anticoagulants, 2014 – 2025 (USD Million)

9.2.7.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.2.7.3. Market size, by application, 2014 – 2025 (USD Million)

9.2.7.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.2.7.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.2.8. Canada

9.2.8.1. Market size, by product, 2014 – 2025 (USD Million)

9.2.8.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.2.8.1.1.1. Market size, by Novel oral anticoagulants, 2014 – 2025 (USD Million)

9.2.8.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.2.8.3. Market size, by application, 2014 – 2025 (USD Million)

9.2.8.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.2.8.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3. Europe

9.3.1. Market size, by country, 2014 – 2025 (USD Million)

9.3.2. Market size, by product, 2014 – 2025 (USD Million)

9.3.2.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.2.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.3. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.4. Market size, by application, 2014 – 2025 (USD Million)

9.3.5. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.6. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.7. Germany

9.3.7.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.7.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.7.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.7.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.7.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.7.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.7.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.8. UK

9.3.8.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.8.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.8.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.8.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.8.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.8.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.8.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.9. France

9.3.9.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.9.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.9.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.9.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.9.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.9.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.9.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.10. Spain

9.3.10.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.10.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.10.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.10.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.10.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.10.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.10.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.11. Italy

9.3.11.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.11.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.11.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.11.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.11.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.11.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.11.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.12. Russia

9.3.12.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.12.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.12.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.12.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.12.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.12.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.12.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.13. Poland

9.3.13.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.13.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.13.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.13.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.13.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.13.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.13.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.14. Switzerland

9.3.14.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.14.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.14.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.14.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.14.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.14.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.14.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.15. Belgium

9.3.15.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.15.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.15.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.15.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.15.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.15.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.15.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.16. Czech Republic

9.3.16.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.16.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.16.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.16.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.16.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.16.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.16.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.17. Netherlands

9.3.17.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.17.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.17.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.17.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.17.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.17.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.17.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.18. Sweden

9.3.18.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.18.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.18.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.18.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.18.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.18.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.18.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.19. Hungary

9.3.19.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.19.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.19.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.19.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.19.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.19.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.19.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.20. Austria

9.3.20.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.20.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.20.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.20.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.20.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.20.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.20.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.21. Portugal

9.3.21.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.21.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.21.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.21.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.21.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.21.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.21.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.22. Denmark

9.3.22.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.22.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.22.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.22.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.22.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.22.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.22.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.23. Norway

9.3.23.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.23.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.23.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.23.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.23.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.23.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.23.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.24. Finland

9.3.24.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.24.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.24.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.24.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.24.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.24.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.24.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.25. Ireland

9.3.25.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.25.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.25.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.25.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.25.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.25.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.25.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.26. Turkey

9.3.26.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.26.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.26.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.26.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.26.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.26.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.26.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.3.27. Greece

9.3.27.1. Market size, by product, 2014 – 2025 (USD Million)

9.3.27.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.3.27.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.3.27.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.3.27.3. Market size, by application, 2014 – 2025 (USD Million)

9.3.27.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.3.27.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4. Asia Pacific

9.4.1. Market size, by country, 2014 – 2025 (USD Million)

9.4.2. Market size, by product, 2014 – 2025 (USD Million)

9.4.2.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.2.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.3. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.4. Market size, by application, 2014 – 2025 (USD Million)

9.4.5. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.6. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.7. China

9.4.7.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.7.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.7.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.7.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.7.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.7.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.7.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.8. Japan

9.4.8.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.8.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.8.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.8.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.8.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.8.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.8.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.9. India

9.4.9.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.9.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.9.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.9.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.9.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.9.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.9.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.10. Australia

9.4.10.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.10.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.10.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.10.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.10.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.10.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.10.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.11. South Korea

9.4.11.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.11.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.11.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.11.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.11.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.11.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.11.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.12. Taiwan

9.4.12.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.12.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.12.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.12.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.12.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.12.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.12.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.13. New Zealand

9.4.13.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.13.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.13.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.13.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.13.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.13.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.13.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.4.14. Singapore

9.4.14.1. Market size, by product, 2014 – 2025 (USD Million)

9.4.14.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.4.14.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.4.14.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.4.14.3. Market size, by application, 2014 – 2025 (USD Million)

9.4.14.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.4.14.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.5. Latin America

9.5.1. Market size, by country, 2014 – 2025 (USD Million)

9.5.2. Market size, by product, 2014 – 2025 (USD Million)

9.5.2.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.2.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.3. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.4. Market size, by application, 2014 – 2025 (USD Million)

9.5.5. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.6. Market size, by end-use, 2014 – 2025 (USD Million)

9.5.7. Brazil

9.5.7.1. Market size, by product, 2014 – 2025 (USD Million)

9.5.7.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.7.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.7.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.7.3. Market size, by application, 2014 – 2025 (USD Million)

9.5.7.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.7.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.5.8. Argentina

9.5.8.1. Market size, by product, 2014 – 2025 (USD Million)

9.5.8.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.8.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.8.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.8.3. Market size, by application, 2014 – 2025 (USD Million)

9.5.8.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.8.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.5.9. Venezuela

9.5.9.1. Market size, by product, 2014 – 2025 (USD Million)

9.5.9.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.9.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.9.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.9.3. Market size, by application, 2014 – 2025 (USD Million)

9.5.9.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.9.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.5.10. Columbia

9.5.10.1. Market size, by product, 2014 – 2025 (USD Million)

9.5.10.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.10.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.10.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.10.3. Market size, by application, 2014 – 2025 (USD Million)

9.5.10.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.10.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.5.11. Mexico

9.5.11.1. Market size, by product, 2014 – 2025 (USD Million)

9.5.11.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.5.11.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.5.11.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.5.11.3. Market size, by application, 2014 – 2025 (USD Million)

9.5.11.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.5.11.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.6. Middle East & Africa

9.6.1. Market size, by country, 2014 – 2025 (USD Million)

9.6.2. Market size, by product, 2014 – 2025 (USD Million)

9.6.2.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.6.2.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.6.3. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.6.4. Market size, by application, 2014 – 2025 (USD Million)

9.6.5. Market size, by route of administration, 2014 – 2025 (USD Million)

9.6.6. Market size, by end-use, 2014 – 2025 (USD Million)

9.6.7. South Africa

9.6.7.1. Market size, by product, 2014 – 2025 (USD Million)

9.6.7.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.6.7.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.6.7.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.6.7.3. Market size, by application, 2014 – 2025 (USD Million)

9.6.7.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.6.7.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.6.8. Saudi Arabia

9.6.8.1. Market size, by product, 2014 – 2025 (USD Million)

9.6.8.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.6.8.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.6.8.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.6.8.3. Market size, by application, 2014 – 2025 (USD Million)

9.6.8.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.6.8.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.6.9. UAE

9.6.9.1. Market size, by product, 2014 – 2025 (USD Million)

9.6.9.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.6.9.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.6.9.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.6.9.3. Market size, by application, 2014 – 2025 (USD Million)

9.6.9.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.6.9.5. Market size, by end-use, 2014 – 2025 (USD Million)

9.6.10. Egypt

9.6.10.1. Market size, by product, 2014 – 2025 (USD Million)

9.6.10.1.1. Market size, by anticoagulant drugs, 2014 – 2025 (USD Million)

9.6.10.1.1.1. Market size, by novel oral anticoagulants, 2014 – 2025 (USD Million)

9.6.10.2. Market size, by atrial fibrillation type, 2014 – 2025 (USD Million)

9.6.10.3. Market size, by application, 2014 – 2025 (USD Million)

9.6.10.4. Market size, by route of administration, 2014 – 2025 (USD Million)

9.6.10.5. Market size, by end-use, 2014 – 2025 (USD Million)

Chapter 10. Company Profiles

10.1. AstraZeneca

10.1.1. Business overview

10.1.2. Financial data

10.1.3. Product landscape

10.1.4. Strategic outlook

10.1.5. SWOT analysis

10.2. Boehringer Ingelheim

10.2.1. Business overview

10.2.2. Financial data

10.2.3. Product landscape

10.2.4. Strategic outlook

10.2.5. SWOT analysis

10.3. Bristol-Myers Squibb

10.3.1. Business overview

10.3.2. Financial data

10.3.3. Product landscape

10.3.4. Strategic outlook

10.3.5. SWOT analysis

10.4. Daiichi Sankyo

10.4.1. Business overview

10.4.2. Financial data

10.4.3. Product landscape

10.4.4. Strategic outlook

10.4.5. SWOT analysis

10.5. GlaxoSmithKline

10.5.1. Business overview

10.5.2. Financial data

10.5.3. Product landscape

10.5.4. Strategic outlook

10.5.5. SWOT analysis

10.6. Johnson and Johnson (JanssenOrtho)

10.6.1. Business overview

10.6.2. Financial data

10.6.3. Product landscape

10.6.4. Strategic outlook

10.6.5. SWOT analysis

10.7. Mitsubishi Tanabe Pharma

10.7.1. Business overview

10.7.2. Financial data

10.7.3. Product landscape

10.7.4. Strategic outlook

10.7.5. SWOT analysis

10.8. Pfizer

10.8.1. Business overview

10.8.2. Financial data

10.8.3. Product landscape

10.8.4. Strategic outlook

10.8.5. SWOT analysis

10.9. Portola Pharmaceuticals

10.9.1. Business overview

10.9.2. Financial data

10.9.3. Product landscape

10.9.4. Strategic outlook

10.9.5. SWOT analysis

10.10. Sanofi

10.10.1. Business overview

10.10.2. Financial data

10.10.3. Product landscape

10.10.4. Strategic outlook

10.10.5. SWOT analysis
 

Data Tables

TABLE 1.    Atrial fibrillation drugs industry 3600 synopsis, 2014 – 2025

TABLE 2.    Global atrial fibrillation drugs market, 2014 – 2018 (USD Million)

TABLE 3.    Global atrial fibrillation drugs market, 2019 – 2025 (USD Million)

TABLE 4.    Global atrial fibrillation drugs market, by product, 2014 - 2018 (USD Million)

TABLE 5.    Global atrial fibrillation drugs market, by product, 2019 - 2025 (USD Million)

TABLE 6.    Global atrial fibrillation drugs market, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 7.    Global atrial fibrillation drugs market, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 8.    Global atrial fibrillation drugs market, by application, 2014 - 2018 (USD Million)

TABLE 9.    Global atrial fibrillation drugs market, by application, 2019 - 2025 (USD Million)

TABLE 10.    Global atrial fibrillation drugs market, by route of administration, 2014 - 2018 (USD Million)

TABLE 11.    Global atrial fibrillation drugs market, by route of administration, 2019 - 2025 (USD Million)

TABLE 12.    Global atrial fibrillation drugs market, by end-use, 2014 - 2018 (USD Million)

TABLE 13.    Global atrial fibrillation drugs market, by product, 2019 - 2025 (USD Million)

TABLE 14.    Global atrial fibrillation drugs market, by region, 2014 – 2018 (USD Million)

TABLE 15.    Global atrial fibrillation drugs market, by region, 2017 – 2024 (USD Million)

TABLE 16.    Industry impact forces

TABLE 17.    Denmark atrial fibrillation reimbursement scenario

TABLE 18.    Antiarrhythmic drugs used to treat atrial fibrillation

TABLE 19.    Anticoagulant drugs used to treat atrial fibrillation

TABLE 20.    Antiarrhythmic drugs market size, by region, 2014 – 2018 (USD Million)

TABLE 21.    Antiarrhythmic drugs market size, by region, 2019 – 2025 (USD Million)

TABLE 22.    Anticoagulant drugs market size, by region, 2014 – 2018 (USD Million)

TABLE 23.    Anticoagulant drugs market size, by region, 2019 – 2025 (USD Million)

TABLE 24.    Vitamin K antagonists (VKA) market size, by region, 2014 – 2018 (USD Million)

TABLE 25.    Vitamin K antagonists (VKA) market size, by region, 2019 – 2025 (USD Million)

TABLE 26.    Novel oral anticoagulants market size, by region, 2014 – 2018 (USD Million)

TABLE 27.    Novel oral anticoagulants market size, by region, 2019 – 2025 (USD Million)

TABLE 28.    Direct thrombin inhibitors market size, by region, 2014 – 2018 (USD Million)

TABLE 29.    Direct thrombin inhibitors market size, by region, 2019 – 2025 (USD Million)

TABLE 30.    Direct factor Xa inhibitors market size, by region, 2014 – 2018 (USD Million)

TABLE 31.    Direct factor Xa inhibitors market size, by region, 2019 – 2025 (USD Million)

TABLE 32.    Paroxysmal market size, by region, 2014 – 2018 (USD Million)

TABLE 33.    Paroxysmal market size, by region, 2019 – 2025 (USD Million)

TABLE 34.    Persistent market size, by region, 2014 – 2018 (USD Million)

TABLE 35.    Persistent market size, by region, 2019 – 2025 (USD Million)

TABLE 36.    Permanent market size, by region, 2014 – 2018 (USD Million)

TABLE 37.    Permanent market size, by region, 2019 – 2025 (USD Million)

TABLE 38.    Heart rhythm control market size, by region, 2014 – 2018 (USD Million)

TABLE 39.    Heart rhythm control market size, by region, 2019 – 2025 (USD Million)

TABLE 40.    Heart rate control market size, by region, 2014 – 2018 (USD Million)

TABLE 41.    Heart rate control market size, by region, 2019 – 2025 (USD Million)

TABLE 42.    Oral market size, by region, 2014 – 2018 (USD Million)

TABLE 43.    Oral market size, by region, 2019 – 2025 (USD Million)

TABLE 44.    Injectable market size, by region, 2014 – 2018 (USD Million)

TABLE 45.    Injectable market size, by region, 2019 – 2025 (USD Million)

TABLE 46.    Hospitals market size, by region, 2014 – 2018 (USD Million)

TABLE 47.    Hospitals market size, by region, 2019 – 2025 (USD Million)

TABLE 48.    Cardiac centers market size, by region, 2014 – 2018 (USD Million)

TABLE 49.    Cardiac centers market size, by region, 2019 – 2025 (USD Million)

TABLE 50.    Ambulatory surgical centers market size, by region, 2014 – 2018 (USD Million)

TABLE 51.    Ambulatory surgical centers market size, by region, 2019 – 2025 (USD Million)

TABLE 52.    Others market size, by region, 2014 – 2018 (USD Million)

TABLE 53.    Others market size, by region, 2019 – 2025 (USD Million)

TABLE 54.    North America atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)

TABLE 55.    North America atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)

TABLE 56.    North America atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 57.    North America atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 58.    North America atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 59.    North America atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 60.    North America atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 61.    North America atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 62.    North America atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 63.    North America atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 64.    North America atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 65.    North America atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 66.    North America atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 67.    North America atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 68.    North America atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 69.    North America atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 70.    U.S. atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 71.    U.S. atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 72.    U.S. atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 73.    U.S. atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 74.    U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 75.    U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 76.    U.S. atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 77.    U.S. atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 78.    U.S. atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 79.    U.S. atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 80.    U.S. atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 81.    U.S. atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 82.    U.S. atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 83.    U.S. atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 84.    Canada atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 85.    Canada atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 86.    Canada atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 87.    Canada atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 88.    Canada atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 89.    Canada atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 90.    Canada atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 91.    Canada atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 92.    Canada atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 93.    Canada atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 94.    Canada atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 95.    Canada atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 96.    Canada atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 97.    Canada atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 98.    Europe atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)

TABLE 99.    Europe atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)

TABLE 100.    Europe atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 101.    Europe atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 102.    Europe atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 103.    Europe atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 104.    Europe atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 105.    Europe atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 106.    Europe atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 107.    Europe atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 108.    Europe atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 109.    Europe atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 110.    Europe atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 111.    Europe atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 112.    Europe atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 113.    Europe atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 114.    Germany atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 115.    Germany atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 116.    Germany atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 117.    Germany atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 118.    Germany atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 119.    Germany atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 120.    Germany atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 121.    Germany atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 122.    Germany atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 123.    Germany atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 124.    Germany atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 125.    Germany atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 126.    Germany atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 127.    Germany atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 128.    UK atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 129.    UK atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 130.    UK atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 131.    UK atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 132.    UK atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 133.    UK atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 134.    UK atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 135.    UK atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 136.    UK atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 137.    UK atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 138.    UK atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 139.    UK atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 140.    UK atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 141.    UK atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 142.    France atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 143.    France atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 144.    France atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 145.    France atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 146.    France atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 147.    France atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 148.    France atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 149.    France atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 150.    France atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 151.    France atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 152.    France atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 153.    France atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 154.    France atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 155.    France atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 156.    Spain atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 157.    Spain atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 158.    Spain atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 159.    Spain atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 160.    Spain atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 161.    Spain atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 162.    Spain atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 163.    Spain atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 164.    Spain atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 165.    Spain atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 166.    Spain atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 167.    Spain atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 168.    Spain atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 169.    Spain atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 170.    Italy atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 171.    Italy atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 172.    Italy atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 173.    Italy atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 174.    Italy atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 175.    Italy atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 176.    Italy atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 177.    Italy atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 178.    Italy atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 179.    Italy atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 180.    Italy atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 181.    Italy atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 182.    Italy atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 183.    Italy atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 184.    Russia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 185.    Russia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 186.    Russia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 187.    Russia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 188.    Russia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 189.    Russia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 190.    Russia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 191.    Russia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 192.    Russia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 193.    Russia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 194.    Russia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 195.    Russia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 196.    Russia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 197.    Russia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 198.    Poland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 199.    Poland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 200.    Poland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 201.    Poland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 202.    Poland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 203.    Poland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 204.    Poland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 205.    Poland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 206.    Poland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 207.    Poland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 208.    Poland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 209.    Poland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 210.    Poland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 211.    Poland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 212.    Switzerland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 213.    Switzerland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 214.    Switzerland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 215.    Switzerland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 216.    Switzerland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 217.    Switzerland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 218.    Switzerland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 219.    Switzerland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 220.    Switzerland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 221.    Switzerland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 222.    Switzerland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 223.    Switzerland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 224.    Switzerland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 225.    Switzerland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 226.    Belgium atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 227.    Belgium atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 228.    Belgium atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 229.    Belgium atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 230.    Belgium atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 231.    Belgium atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 232.    Belgium atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 233.    Belgium atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 234.    Belgium atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 235.    Belgium atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 236.    Belgium atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 237.    Belgium atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 238.    Belgium atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 239.    Belgium atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 240.    Czech Republic atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 241.    Czech Republic atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 242.    Czech Republic atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 243.    Czech Republic atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 244.    Czech Republic atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 245.    U.S. atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 246.    Czech Republic atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 247.    Czech Republic atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 248.    Czech Republic atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 249.    Czech Republic atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 250.    Czech Republic atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 251.    Czech Republic atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 252.    Czech Republic atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 253.    Czech Republic atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 254.    Netherlands atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 255.    Netherlands atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 256.    Netherlands atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 257.    Netherlands atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 258.    Netherlands atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 259.    Netherlands atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 260.    Netherlands atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 261.    Netherlands atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 262.    Netherlands atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 263.    Netherlands atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 264.    Netherlands atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 265.    Netherlands atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 266.    Netherlands atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 267.    Netherlands atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 268.    Sweden atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 269.    Sweden atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 270.    Sweden atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 271.    Sweden atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 272.    Sweden atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 273.    Sweden atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 274.    Sweden atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 275.    Sweden atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 276.    Sweden atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 277.    Sweden atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 278.    Sweden atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 279.    Sweden atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 280.    Sweden atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 281.    Sweden atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 282.    Hungary atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 283.    Hungary atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 284.    Hungary atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 285.    Hungary atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 286.    Hungary atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 287.    Hungary atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 288.    Hungary atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 289.    Hungary atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 290.    Hungary atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 291.    Hungary atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 292.    Hungary atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 293.    Hungary atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 294.    Hungary atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 295.    Hungary atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 296.    Austria atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 297.    Austria atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 298.    Austria atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 299.    Austria atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 300.    Austria atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 301.    Austria atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 302.    Austria atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 303.    Austria atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 304.    Austria atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 305.    Austria atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 306.    Austria atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 307.    Austria atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 308.    Austria atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 309.    Austria atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 310.    Portugal atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 311.    Portugal atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 312.    Portugal atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 313.    Portugal atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 314.    Portugal atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 315.    Portugal atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 316.    Portugal atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 317.    Portugal atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 318.    Portugal atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 319.    Portugal atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 320.    Portugal atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 321.    Portugal atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 322.    Portugal atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 323.    Portugal atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 324.    Denmark atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 325.    Denmark atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 326.    Denmark atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 327.    Denmark atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 328.    Denmark atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 329.    Denmark atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 330.    Denmark atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 331.    Denmark atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 332.    Denmark atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 333.    Denmark atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 334.    Denmark atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 335.    Denmark atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 336.    Denmark atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 337.    Denmark atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 338.    Norway atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 339.    Norway atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 340.    Norway atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 341.    Norway atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 342.    Norway atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 343.    Norway atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 344.    Norway atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 345.    Norway atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 346.    Norway atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 347.    Norway atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 348.    Norway atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 349.    Norway atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 350.    Norway atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 351.    Norway atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 352.    Finland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 353.    Finland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 354.    Finland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 355.    Finland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 356.    Finland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 357.    Finland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 358.    Finland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 359.    Finland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 360.    Finland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 361.    Finland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 362.    Finland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 363.    Finland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 364.    Finland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 365.    Finland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 366.    Ireland atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 367.    Ireland atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 368.    Ireland atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 369.    Ireland atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 370.    Ireland atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 371.    Ireland atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 372.    Ireland atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 373.    Ireland atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 374.    Ireland atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 375.    Ireland atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 376.    Ireland atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 377.    Ireland atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 378.    Ireland atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 379.    Ireland atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 380.    Turkey atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 381.    Turkey atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 382.    Turkey atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 383.    Turkey atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 384.    Turkey atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 385.    Turkey atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 386.    Turkey atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 387.    Turkey atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 388.    Turkey atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 389.    Turkey atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 390.    Turkey atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 391.    Turkey atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 392.    Turkey atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 393.    Turkey atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 394.    Greece atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 395.    Greece atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 396.    Greece atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 397.    Greece atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 398.    Greece atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 399.    Greece atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 400.    Greece atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 401.    Greece atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 402.    Greece atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 403.    Greece atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 404.    Greece atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 405.    Greece atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 406.    Greece atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 407.    Greece atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 408.    Asia Pacific atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)

TABLE 409.    Asia Pacific atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)

TABLE 410.    Asia Pacific atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 411.    Asia Pacific atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 412.    Asia Pacific atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 413.    Asia Pacific atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 414.    Asia Pacific atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 415.    Asia Pacific atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 416.    Asia Pacific atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 417.    Asia Pacific atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 418.    Asia Pacific atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 419.    Asia Pacific atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 420.    Asia Pacific atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 421.    Asia Pacific atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 422.    Asia Pacific atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 423.    Asia Pacific atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 424.    China atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 425.    China atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 426.    China atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 427.    China atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 428.    China atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 429.    China atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 430.    China atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 431.    China atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 432.    China atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 433.    China atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 434.    China atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 435.    China atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 436.    China atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 437.    China atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 438.    Japan atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 439.    Japan atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 440.    Japan atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 441.    Japan atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 442.    Japan atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 443.    Japan atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 444.    Japan atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 445.    Japan atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 446.    Japan atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 447.    Japan atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 448.    Japan atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 449.    Japan atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 450.    Japan atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 451.    Japan atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 452.    India atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 453.    India atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 454.    India atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 455.    India atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 456.    India atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 457.    India atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 458.    India atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 459.    India atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 460.    India atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 461.    India atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 462.    India atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 463.    India atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 464.    India atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 465.    India atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 466.    Australia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 467.    Australia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 468.    Australia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 469.    Australia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 470.    Australia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 471.    Australia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 472.    Australia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 473.    Australia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 474.    Australia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 475.    Australia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 476.    Australia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 477.    Australia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 478.    Australia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 479.    Australia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 480.    South Korea atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 481.    South Korea atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 482.    South Korea atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 483.    South Korea atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 484.    South Korea atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 485.    South Korea atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 486.    South Korea atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 487.    South Korea atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 488.    South Korea atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 489.    South Korea atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 490.    South Korea atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 491.    South Korea atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 492.    South Korea atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 493.    South Korea atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 494.    Taiwan atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 495.    Taiwan atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 496.    Taiwan atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 497.    Taiwan atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 498.    Taiwan atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 499.    Taiwan atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 500.    Taiwan atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 501.    Taiwan atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 502.    Taiwan atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 503.    Taiwan atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 504.    Taiwan atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 505.    Taiwan atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 506.    Taiwan atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 507.    Taiwan atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 508.    New Zealand atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 509.    New Zealand atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 510.    New Zealand atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 511.    New Zealand atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 512.    New Zealand atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 513.    New Zealand atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 514.    New Zealand atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 515.    New Zealand atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 516.    New Zealand atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 517.    New Zealand atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 518.    New Zealand atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 519.    New Zealand atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 520.    New Zealand atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 521.    New Zealand atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 522.    Singapore atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 523.    Singapore atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 524.    Singapore atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 525.    Singapore atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 526.    Singapore atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 527.    Singapore atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 528.    Singapore atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 529.    Singapore atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 530.    Singapore atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 531.    Singapore atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 532.    Singapore atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 533.    Singapore atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 534.    Singapore atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 535.    Singapore atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 536.    Latin America atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)

TABLE 537.    Latin America atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)

TABLE 538.    Latin America atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 539.    Latin America atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 540.    Latin America atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 541.    Latin America atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 542.    Latin America atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 543.    Latin America atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 544.    Latin America atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 545.    Latin America atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 546.    Latin America atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 547.    Latin America atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 548.    Latin America atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 549.    Latin America atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 550.    Latin America atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 551.    Latin America atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 552.    Brazil atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 553.    Brazil atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 554.    Brazil atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 555.    Brazil atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 556.    Brazil atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 557.    Brazil atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 558.    Brazil atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 559.    Brazil atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 560.    Brazil atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 561.    Brazil atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 562.    Brazil atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 563.    Brazil atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 564.    Brazil atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 565.    Brazil atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 566.    Argentina atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 567.    Argentina atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 568.    Argentina atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 569.    Argentina atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 570.    Argentina atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 571.    Argentina atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 572.    Argentina atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 573.    Argentina atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 574.    Argentina atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 575.    Argentina atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 576.    Argentina atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 577.    Argentina atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 578.    Argentina atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 579.    Argentina atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 580.    Venezuela atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 581.    Venezuela atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 582.    Venezuela atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 583.    Venezuela atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 584.    Venezuela atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 585.    Venezuela atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 586.    Venezuela atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 587.    Venezuela atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 588.    Venezuela atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 589.    Venezuela atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 590.    Venezuela atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 591.    Venezuela atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 592.    Venezuela atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 593.    Venezuela atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 594.    Columbia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 595.    Columbia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 596.    Columbia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 597.    Columbia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 598.    Columbia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 599.    Columbia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 600.    Columbia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 601.    Columbia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 602.    Columbia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 603.    Columbia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 604.    Columbia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 605.    Columbia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 606.    Columbia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 607.    Columbia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 608.    Mexico atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 609.    Mexico atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 610.    Mexico atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 611.    Mexico atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 612.    Mexico atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 613.    Mexico atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 614.    Mexico atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 615.    Mexico atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 616.    Mexico atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 617.    Mexico atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 618.    Mexico atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 619.    Mexico atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 620.    Mexico atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 621.    Mexico atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 622.    MEA atrial fibrillation drugs market size, by country, 2014 - 2018 (USD Million)

TABLE 623.    MEA atrial fibrillation drugs market size, by country, 2019 - 2025 (USD Million)

TABLE 624.    MEA atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 625.    MEA atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 626.    MEA atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 627.    MEA atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 628.    MEA atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 629.    MEA atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 630.    MEA atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 631.    MEA atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 632.    MEA atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 633.    MEA atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 634.    MEA atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 635.    MEA atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 636.    MEA atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 637.    MEA atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 638.    South Africa atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 639.    South Africa atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 640.    South Africa atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 641.    South Africa atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 642.    South Africa atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 643.    South Africa atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 644.    South Africa atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 645.    South Africa atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 646.    South Africa atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 647.    South Africa atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 648.    South Africa atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 649.    South Africa atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 650.    South Africa atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 651.    South Africa atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 652.    Saudi Arabia atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 653.    Saudi Arabia atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 654.    Saudi Arabia atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 655.    Saudi Arabia atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 656.    Saudi Arabia atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 657.    Saudi Arabia atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 658.    Saudi Arabia atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 659.    Saudi Arabia atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 660.    Saudi Arabia atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 661.    Saudi Arabia atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 662.    Saudi Arabia atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 663.    Saudi Arabia atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 664.    Saudi Arabia atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 665.    Saudi Arabia atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 666.    UAE atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 667.    UAE atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 668.    UAE atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 669.    UAE atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 670.    UAE atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 671.    UAE atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 672.    UAE atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 673.    UAE atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 674.    UAE atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 675.    UAE atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 676.    UAE atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 677.    UAE atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 678.    UAE atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 679.    UAE atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)

TABLE 680.    Egypt atrial fibrillation drugs market size, by product, 2014 - 2018 (USD Million)

TABLE 681.    Egypt atrial fibrillation drugs market size, by product, 2019 - 2025 (USD Million)

TABLE 682.    Egypt atrial fibrillation drugs market size, by anticoagulant drugs, 2014 - 2018 (USD Million)

TABLE 683.    Egypt atrial fibrillation drugs market size, by anticoagulant drugs, 2019 - 2025 (USD Million)

TABLE 684.    Egypt atrial fibrillation drugs market size, by novel oral anticoagulants, 2014 - 2018 (USD Million)

TABLE 685.    Egypt atrial fibrillation drugs market size, by novel oral anticoagulants, 2019 - 2025 (USD Million)

TABLE 686.    Egypt atrial fibrillation drugs market size, by atrial fibrillation type, 2014 - 2018 (USD Million)

TABLE 687.    Egypt atrial fibrillation drugs market size, by atrial fibrillation type, 2019 - 2025 (USD Million)

TABLE 688.    Egypt atrial fibrillation drugs market size, by application, 2014 - 2018 (USD Million)

TABLE 689.    Egypt atrial fibrillation drugs market size, by application, 2019 - 2025 (USD Million)

TABLE 690.    Egypt atrial fibrillation drugs market size, by route of administration, 2014 - 2018 (USD Million)

TABLE 691.    Egypt atrial fibrillation drugs market size, by route of administration, 2019 - 2025 (USD Million)

TABLE 692.    Egypt atrial fibrillation drugs market size, by end-use, 2014 - 2018 (USD Million)

TABLE 693.    Egypt atrial fibrillation drugs market size, by end-use, 2019 - 2025 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global atrial fibrillation drugs market, 2014 – 2025 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Growth potential analysis, by atrial fibrillation type

FIG. 5    Growth potential analysis, by application

FIG. 6    Growth potential analysis, by route of administration

FIG. 7    Growth potential analysis, by end-use

FIG. 8    Global atrial fibrillation prevalence, 2017

FIG. 9    North America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 10    Europe proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 11    Asia Pacific proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 12    Latin America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 13    MEA proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 14    North America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 15    Europe proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 16    Asia Pacific proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 17    Latin America proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 18    MEA proportion of atrial fibrillation patients on atrial fibrillation drug therapy, 2018

FIG. 19    Antiarrhythmic drug pricing analysis

FIG. 20    Anticoagulant drug pricing analysis

FIG. 21    Major atrial fibrillation anticoagulant drugs market share analysis, 2017

FIG. 22    Global atrial fibrillation drugs prescription pattern, 2014 - 2025

FIG. 23    Antiarrhythmic drug global prescription pattern, 2014 - 2025

FIG. 24    Anticoagulant drug global prescription pattern, 2014 - 2025

FIG. 25    Vitamin K antagonists global prescription pattern, 2014 - 2025

FIG. 26    Novel oral anticoagulants global prescription pattern, 2014 - 2025

FIG. 27    Direct thrombin inhibitors (Dabigatran - Pradaxa) global prescription pattern, 2014 - 2025

FIG. 28    Direct factor Xa inhibitors) global prescription pattern, 2014 - 2025

FIG. 29    Apixaban (Eliquis) global prescription pattern

FIG. 30    Betrixaban (Bevyxxa) global prescription pattern

FIG. 31    Edobaxan (Savaysa/Lixiana) global prescription pattern

FIG. 32    Rivaroxaban (Xarelto) global prescription pattern

FIG. 33    Porter’s analysis

FIG. 34    Strategy dashboard

FIG. 35    PESTEL analysis

 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Apr 2019
  • Pages: 350
  • Tables: 693
  • Charts / Figures: 35
  • Companies covered: 10
  • Countries covered: 40

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X